Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $8.8900 (-2.58%) ($8.8550 - $8.8900) on Wed. Jul. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 35 | Latest Price | $8.8900(-2.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -0.5% a day on average for past five trading days. | Weekly Trend | FOLD declines -4.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(57%) IWO(53%) IWM(50%) XBI(50%) IWC(49%) | Factors Impacting FOLD price | FOLD will decline at least -1.255% in a week (0% probabilities). VIXM(-30%) VXX(-14%) UUP(-11%) UNG(-7%) TLT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $0.47(-94.71%) | Resistance Level | $9.73 | 5 Day Moving Average | $9.24(-3.79%) | 10 Day Moving Average | $9.37(-5.12%) | 20 Day Moving Average | $9.73(-8.63%) | To recent high | -17.1% | To recent low | 2.2% | Market Cap | $2.296b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |